Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Proteins & Peptides
Filter     Order     Display # 
Date Item Title
11 Jun 2006 Late Breaking Data at ADA 2006 Shows Amylin-Leptin Co-Administration Reduces Body Weight and Body Fat in Animal Studies
11 Jun 2006 BYETTA(R) Extension Study Shows Sustained Improvements in Blood Glucose Control and Progressive Weight Loss After Two Years
11 Jun 2006 Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control in Patients with Type 2 Diabetes
09 Jun 2006 Acologix Presents Preclinical Data On Bone Formation And Maturation Stimulated By AC-100 At The European Orthopedic Research Society Meeting
08 Jun 2006 Repligen Initiates Clinical Trial of Secretin for MRI Imaging of the Pancreas
08 Jun 2006 NeoPharm Announces PRECISE Trial Has Reached Criteria for Interim Efficacy Analysis; Independent Data Monitoring Committee to Conduct Interim Efficacy Analysis
08 Jun 2006 Nastech Submits Investigational New Drug Application for PYY3-36 Nasal Spray to Treat Obesity
08 Jun 2006 Clinical Data on Molecular Imaging of Breast Cancer Metastases using anti-HER2 Affibody® molecules
07 Jun 2006 Betaferon approved in Europe as a first-line treatment for the earliest stages of multiple sclerosis
07 Jun 2006 Jerini Completes Randomization of Last Patient in Phase III European Clinical Trial (FAST-2) of Icatibant for the Treatment of Hereditary Angioedema
07 Jun 2006 Discovery Labs Withdraws European Marketing Application for Surfaxin
07 Jun 2006 Positive Interim Results for Gloucester Pharmaceutical's Pivotal Trial of Depsipeptide Reported at the 2006 Annual Meeting of The American Society of Clinical Oncology
06 Jun 2006 Nastech Enters Into Supply Agreement with Procter & Gamble for Parathyroid Hormone (PTH1-34) Nasal Spray
06 Jun 2006 Public Statement On Infergen (Interferon alfacon-1) Withdrawal Of The Marketing Authorisation In The European Union
06 Jun 2006 Novartis strengthens infectious disease portfolio by acquiring rights to Albuferon(TM), a hepatitis C interferon drug set to enter Phase III trials
06 Jun 2006 Lilly and Alkermes Complete Patient Enrollment for Phase 3 Safety Study for Inhaled Insulin for the Treatment of Diabetes
06 Jun 2006 Active Biotech's ANYARA cancer project presented at ASCO in Atlanta
06 Jun 2006 ZymoGenetics Reports Encouraging IL-21 Phase 1b Results in Metastatic Melanoma and Renal Cell Cancer Presented at ASCO Meeting
06 Jun 2006 Study Demonstrates Safety of Promising Investigational Treatment for Deadly Brain Cancer; Results Establish Safe Dosages for Larger-Scale Study of 131I-TM-601 in Treatment of High-Grade Gliomas
04 Jun 2006 Interim Data Suggest Potential Benefits of Aranesp(R) Dosed Every Three Weeks with Intravenous Iron for Chemotherapy-Induced Anemia; 94 Percent of Patients Achieved Target Hemoglobin Level
04 Jun 2006 Interim Phase 2 Aranesp(R) Data Suggest Major Response after 27/28 Weeks of Treatment for Anemia in Patients with Myelodysplastic Syndromes (MDS)
04 Jun 2006 Adherex Presents Phase Ib Data From European ADH-1 Trial at ASCO 2006 Annual Meeting: ADH-1 was well tolerated and showed additional evidence of anti-tumor activity
03 Jun 2006 Allon begins enrolment for AL-208 Phase II clinical trial
02 Jun 2006 ATryn Receives CHMP Recommendation To Grant Market Authorization
01 Jun 2006 Nuvelo Announces Completion of Phase 2 Heparin Replacement Trial Evaluating rNAPc2 in Acute Coronary Syndromes
01 Jun 2006 The Debiopharm Group To Initiate Confirmatory Phase III Trial For Sanvar In Esophageal Variceal Bleeding
01 Jun 2006 Regeneron Receives Fast-Track Designation For The Il-1 Trap In CIAS1-Associated Periodic Syndromes (Caps)
31 May 2006 Transition Therapeutics Completes Target Enrolment for Clinical Trial of Lead Regenerative Product, E1-I.N.T.(TM) in Type I Diabetes Patients
31 May 2006 European Commission Grants Orphan Medicinal Product Designation to Increlex for the Treatment of Primary IGFD
31 May 2006 Sandoz gets precedent-setting US approval for Omnitrope as first followon version of a previously approved recombinant biotechnology drug
30 May 2006 CuraGen Initiates Second Phase II Clinical Trial with Velafermin
26 May 2006 Emisphere Reports Completion of Planned Preclinical Safety Studies for Oral Calcitonin Program
25 May 2006 SciClone Reports Final Results From Second ZADAXIN U.S. Phase 3 Hepatitis C Trial
25 May 2006 Phosphagenics announces positive preclinical trial results for its transdermal insulin formulation
24 May 2006 Promising Early Clinical Trials for Bayer’s longer acting Kogenate® Product
24 May 2006 New Research Signals Second Indication for Interferon Beta Programme in COPD
24 May 2006 CEL-SCI Presents Long-Term Survival Data With Its Anti-Cancer Drug Multikine(R)
24 May 2006 Amarillo Biosciences Announces Phase II Study of Orally Administered Interferon Alpha in the Treatment of Oral Warts in HIV-Positive Patients
23 May 2006 Schering-Plough Initiates PEG-INTRON 'PROTECT' Study in Liver Transplant Patients with Recurrent Hepatitis C
23 May 2006 Viragen to Highlight Multiferon(R) Treatment Advantages at Melanoma Conference
23 May 2006 New Study Shows Novel Therapy May Produce Early Remission in Crohn's Patients
22 May 2006 Debiopharm And TcLand Sign R&D And Exclusive License Option For The Development Of Sc28AT In Autoimmune Diseases And Transplantation
19 May 2006 Large Head-to-Head Study of Aranesp(R) Dosed Every Two Weeks versus Epoetin Alfa Dosed Weekly Published in the Journal of Clinical Oncology
19 May 2006 QLT Delays Initiation Of Phase IIa Atrigel/Octreotide Program
18 May 2006 CVBT Achieves Safety Milestone in Clinical Heart Trial
18 May 2006 The next generation of interferons needs improvement in efficacy and safety
17 May 2006 Shire Provides Update on U.S. Marketing Application of ELAPRASE
16 May 2006 Dyax Provides Update on Regulatory Pathway for DX-88; Phase III Trial on Track to Complete 2H06
16 May 2006 Oragenics' Lead Antibiotic Proves Effective in Animal Infection Model
12 May 2006 Tercica Presents Updated Increlex Long-Term Treatment Data at the 2006 Pediatric Endocrinology Nursing Society Convention; Data Represents 321 Patient-Years of Treatment with Increlex
 
<< Start < Prev 21 22 23 24 25 26 27 28 29 Next > End >>
Results 1201 - 1250 of 1426

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics